Nu-Med Plus, Inc.
NUMD
$0.02
$0.0168.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.38% | -41.95% | -35.00% | -9.22% | -83.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.38% | -41.95% | -35.00% | -9.22% | -83.18% |
| Operating Income | -5.38% | 41.95% | 35.00% | 9.22% | 83.18% |
| Income Before Tax | -18.87% | 35.83% | 32.37% | 8.72% | 81.27% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.87% | 35.83% | 32.37% | 8.72% | 81.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.87% | 35.83% | 32.37% | 8.72% | 81.27% |
| EBIT | -5.38% | 41.95% | 35.00% | 9.22% | 83.18% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -100.00% | 50.00% | 50.00% | 33.33% | 85.71% |
| Normalized Basic EPS | 0.00% | 0.00% | 0.00% | 50.00% | 75.00% |
| EPS Diluted | -100.00% | 50.00% | 50.00% | 33.33% | 85.71% |
| Normalized Diluted EPS | 0.00% | 0.00% | 0.00% | 50.00% | 75.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 1.09% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 1.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |